Their outlook statement last quarterly suggests profit for Q2 will be stronger compared to Q1 of $12m , lets assume profit for Q2 comes in at $18m , Q3 of 21m , Q4 of 25m that will give them a PE of 26.4 at the current share price. Is the stock price cheap if they make these numbers ??. Anyone know what PE multiples other Global vitamin companies trade at ??.
OUTLOOK
“As advised when we announced our full year results, our first quarter sales have been impacted by changes in market dynamics in Australia. Pleasingly, we entered the second quarter with an improving sales and profit trajectory, there are positive sales trends that indicate overstocking is easing, consumer demand remains robust and we have been able to capture significant new sales in China,” said Christine Holgate. “Whilst we don’t expect to match last year’s exceptional performance for the full year, we are pleased with the improving trends and are encouraged by new growth opportunities. At this stage, we anticipate a stronger second quarter compared to the first quarter sales and profit. The Board remains confident in the Group’s strategic focus and long-term growth prospects.”
